Second IPO From Canara’s Bag, Submits Draft Papers for Life Insurance Arm

0

In a notable development in the Indian insurance sector, Canara HSBC Life Insurance Company has filed its Draft Red Herring Prospectus (DRHP) with the Securities and Exchange Board of India (SEBI), marking its intent to hit the primary market with a purely Offer-for-Sale (OFS) based IPO. The move signals a major reshuffling of stakes among its existing promoters and key shareholders.

Canara HSBC Life Insurance Company IPO

Canara HSBC Life Insurance IPO Structure: Pure OFS – No Fresh Issue

Canara HSBC Life Insurance IPO will be an Offer for Sale (OFS) of up to 237.5 million equity shares of face value INR 10 each. There will be no fresh issue. Canara HSBC Life Insurance will not receive any IPO proceeds. The entire proceeds will go to the selling shareholders.

The selling shareholders are:

  • Canara Bank (51% stake) – offering up to 137.75 million shares.
  • HSBC Insurance (Asia-Pacific) Holdings Limited (26% stake) – offering 4.75 million shares.
  • Punjab National Bank (23% stake) – offering 95 million shares.

All three major shareholders are partially exiting to unlock value.

Lead Managers and Listing

The issue is managed by:

  • SBI Capital Markets
  • BNP Paribas
  • HSBC Securities and Capital Markets (India)
  • JM Financial
  • Motilal Oswal Investment Advisors

KFin Technologies is the registrar of the issue.

Company Snapshot

Canara HSBC Life Insurance Company, headquartered in Gurugram, was incorporated in 2007 and operates through a strong bancassurance model – leveraging the vast network of Canara Bank (over 9,800 branches) and HSBC India (26 branches) and eight regional rural banks.

Over its 17-year journey, the company has evolved into a leading bank-led private life insurer:

  • It ranks third highest in AUM among public sector-promoted life insurers as of March 2024.
  • It has been among the top five bank-led life insurers in India by number of lives covered.
  • Bancassurance contributed a dominant share of new business premiums — over 88.56% in the nine months ending December 2024.

The insurer offers a diversified portfolio of 17 individual and 7 group products, including savings plans, term protection, retirement products, and government-backed schemes like PMJJBY.

Financial Performance

The company’s financials highlight an impressive growth story:

  • Premiums earned (net) stood at INR 5,146.8 crore for the nine months ended 31 December 2024.
  • Profit After Tax (PAT) grew at a CAGR of 232.61% over FY22–FY24, reaching INR 113.32 crore in FY24.
  • For the nine months ended December 2024, the PAT was already INR 84.89 crore.
  • Embedded Value (EV) increased from INR 4,271.9 crore (March 2023) to INR 5,929.5 crore (December 2024).
  • The solvency ratio stands strong at 215%, well above the regulatory requirement of 150%.

Furthermore, operational efficiency remains robust:

  • The company’s 13th month persistency ratio (by premium) rose to 83.45%, showcasing strong customer stickiness.
  • Operating Return on Embedded Value (RoEV) was 20.42% for the nine months ended December 2024, reflecting strong profitability.

The company has embraced digital transformation, with 99% of policy applications processed digitally and a heavy focus on ‘straight-through processing’ (72% penetration).

Cash Flow and Balance Sheet Insights

  • Operating cash flow turned negative at INR (181.2) crore in the nine months of FY25 due to high claim payments and commissions, compared to positive flows in previous years.
  • Investing cash flows were also negative, largely due to aggressive investments in fixed income and equity instruments.
  • Despite pressures, the cash and equivalents at year-end remained healthy at INR 1,347.20 crore.

Why This OFS Matters

This IPO is strategically significant for several reasons:

  • Stake Rebalancing: Existing promoters Canara Bank, HSBC, and PNB are partly monetizing their investments — typical for mature bancassurance-driven models.
  • Investor Opportunity: The issue opens investment avenues into a rare entity — a profitable, mid-sized, bank-led life insurance player in India with a strong distribution backbone.
  • No Dilution: The absence of a fresh issue ensures that there is no equity dilution for future shareholders.
  • Market Timing: It comes at a time when the insurance penetration in India is on the rise, regulatory frameworks are favorable, and bancassurance models are gaining prominence.
IPO, Startup Funding

Conclusion

Canara HSBC Life Insurance’s IPO paints the picture of a financially solid, operationally efficient, and strategically well-placed insurer. While investors should carefully evaluate the pricing (to be finalized), the company’s strong AUM growth, profitability, bancassurance-driven market presence, and digital adoption make it a worthy contender for those looking to diversify into India’s expanding insurance sector.

For more details related to IPO GMP, SEBI IPO Approval, and Live Subscription stay tuned to IPO Central.

LEAVE A REPLY

Please enter your comment!
Please enter your name here